1. Home
  2. TARA vs IDE Comparison

TARA vs IDE Comparison

Compare TARA & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

SELL

Current Price

$2.30

Market Cap

159.6M

Sector

Health Care

ML Signal

SELL

Logo Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

IDE

Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

SELL

Current Price

$11.60

Market Cap

179.6M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
TARA
IDE
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
159.6M
179.6M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TARA
IDE
Price
$2.30
$11.60
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
★ $25.33
N/A
AVG Volume (30 Days)
★ 852.9K
45.1K
Earning Date
11-06-2026
01-01-0001
Dividend Yield
N/A
★ 8.83%
EPS Growth
★ 38.25
N/A
EPS
N/A
★ N/A
Revenue
★ $2,948,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$11.36
52 Week High
$7.82
$14.30

Technical Indicators

Market Signals
Indicator
TARA
IDE
Relative Strength Index (RSI) 42.02 39.23
Support Level $2.19 $11.54
Resistance Level $2.73 $13.95
Average True Range (ATR) 0.21 0.24
MACD 0.03 0.00
Stochastic Oscillator 34.43 10.66

Price Performance

Historical Comparison
TARA
IDE

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: